Bausch Health Rejects Bondholders’ Debt Proposals, Explores Sale of Vision Care Unit
The potential sale of its 88% stake in Bausch + Lomb could generate billions for creditors and shareholders of the indebted ...
Bausch Health call volume above normal and directionally bullish
Bullish option flow detected in Bausch Health (BHC) with 5,026 calls trading, 2x expected, and implied vol increasing over 2 ...
Bausch Health Shares Fall after Rejecting Bondholder Proposals to Restructure Debt
Bausch Health has recently changed its strategy for Bausch + Lomb, looking to sell the segment which has a market capitalization of nearly $8 billion. The potential sale of Bausch + Lomb is a break ...
Bausch Health Companies (TSE:BHC) Lifted to Hold at Evercore ISI
Evercore ISI upgraded shares of Bausch Health Companies (TSE:BHC – Free Report) to a hold rating in a research note published ...
GlobalData on MSN6d
Bausch + Lomb wins FDA nod for enVista Envy range of intraocular lenses
The approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces
Bausch Health faces $21 billion in debt, with $10 billion due by 2027 and a $2.4 billion loan due next year. Private equity ...
Evercore ISI Reaffirms Their Hold Rating on Bausch Health Companies (BHC)
In a report released today, Umer Raffat from Evercore ISI maintained a Hold rating on Bausch Health Companies (BHC – Research Report).
Bausch Health Companies (NYSE:BHC shareholders incur further losses as stock declines 4.4% this week, taking three-year losses to 72%
Bausch Health Companies Inc. ( NYSE:BHC ) shareholders should be happy to see the share price up 26% in the last ...
Bausch + Lomb (NYSE:BLCO) Stock Rating Upgraded by Evercore ISI
Evercore ISI upgraded shares of Bausch + Lomb (NYSE:BLCO – Free Report) from an in-line rating to an outperform rating in a ...